120 related articles for article (PubMed ID: 6852993)
1. The efficacy of amiodarone for ventricular arrhythmias can be predicted with clinical electrophysiological studies.
McGovern B; Ruskin JN
Int J Cardiol; 1983 Apr; 3(1):71-6. PubMed ID: 6852993
[No Abstract] [Full Text] [Related]
2. The efficacy of amiodarone for ventricular arrhythmias cannot be predicted with clinical electrophysiological studies.
Waxman HL
Int J Cardiol; 1983 Apr; 3(1):76-80. PubMed ID: 6852994
[No Abstract] [Full Text] [Related]
3. Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation.
Heger JJ; Prystowsky EN; Miles WM; Zipes DP
Br J Clin Pract Suppl; 1986 Apr; 44():16-27. PubMed ID: 3089256
[No Abstract] [Full Text] [Related]
4. Transient exacerbation followed by control of ventricular tachycardia with amiodarone.
Mostow ND; Vrobel TR; Rakita L
Am Heart J; 1986 Jan; 111(1):178-80. PubMed ID: 3946146
[No Abstract] [Full Text] [Related]
5. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of amiodarone.
Marcus FI
Ann N Y Acad Sci; 1984; 427():112-26. PubMed ID: 6378011
[No Abstract] [Full Text] [Related]
7. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR
Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
[TBL] [Abstract][Full Text] [Related]
9. Ventricular arrhythmias: use of electrophysiologic studies.
Horowitz LN; Spielman SR; Greenspan AM; Webb CR; Kay HR
Am Heart J; 1983 Oct; 106(4 Pt 2):881-6. PubMed ID: 6613834
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
Schützenberger W; Leisch F; Kerschner K; Harringer W; Herbinger W
Br Heart J; 1989 Nov; 62(5):367-71. PubMed ID: 2590589
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK
Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112
[TBL] [Abstract][Full Text] [Related]
12. Effect of amiodarone on electric induction, morphology, and rate of ventricular tachycardia and its relation to clinical efficacy.
Reddy CP; Kuo CS; Jivrajka V
Pacing Clin Electrophysiol; 1984 Nov; 7(6 Pt 1):1055-62. PubMed ID: 6209624
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
Heger JJ; Prystowsky EN; Zipes DP
Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
[TBL] [Abstract][Full Text] [Related]
14. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
Morady F; Scheinman MM; Hess DS
Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
Saksena S; Rothbart ST; Shah Y; Cappello G
Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016
[TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
Nademanee K; Hendrickson J; Kannan R; Singh BN
Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
[No Abstract] [Full Text] [Related]
18. Clinical efficacy of amiodarone as an antiarrhythmic agent.
Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
[TBL] [Abstract][Full Text] [Related]
19. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
[TBL] [Abstract][Full Text] [Related]
20. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.
Waxman HL; Groh WC; Marchlinski FE; Buxton AE; Sadowski LM; Horowitz LN; Josephson ME; Kastor JA
Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
